Theralase appoints Cordoba as Therapeutic Division GM

March 21, 2011
Toronto, ON, Canada--Theralase announced that Jorge Córdoba has been appointed as general manager - Therapeutic Division for its therapeutic medical laser products.

Toronto, ON, Canada--Theralase Technologies (TSXV: TLT) announced that effective immediately, Jorge Córdoba has been appointed as general manager - Therapeutic Division for Theralase’s line of proprietary therapeutic medical laser products. Córdoba, reporting to Roger Dumoulin-White, president and CEO, will have general management responsibilities over the sales, marketing, production, clinical services and regulatory affairs departments.

Córdoba has over 16 years of experience in leading numerous high-technology manufacturing companies to success, providing general management expertise in local and international sales, marketing, production, operations and regulatory affairs. His last position was as director of operations for a $17 million aerospace organization turnaround situation, in which Córdoba, through a number of different initiatives, achieved an increase in productivity of over 400% in less than 2 years. Prior to that, Córdoba successfully launched a 250,000 square foot, $40 million facility for manufacturing high precision assemblies for a division of Magna Inc. In an earlier position, he was the sales and marketing manager for a high tech equipment manufacturer, responsible for sales in excess of $10 million annually.

“I am excited to be part of such a world-class medical organization as Theralase. Under the direction of Roger Dumoulin-White, Theralase has systematically developed valuable intellectual property in the medical laser space and in my estimation is now positioned to rapidly execute on its growth strategy,” said Córdoba. “I accepted the position because Theralase has such wonderful upside, attracting a dedicated team of professionals able to take this intellectual property to the next level and dramatically increase its revenue over the next few years. I look forward to following in Roger’s footsteps to dramatically grow the therapeutic division of the Company.”

Córdoba obtained a Master’s of Business from the Ivey School of Business, University of Western Ontario, London, Ontario in 2005, a Master’s of Science in Advanced Manufacturing Technology from the University of Manchester, Manchester, England in 1993 and a Bachelor of Mechanical-Electrical Engineering from the National University, Mexico City, Mexico in 1989.

SOURCE: Theralase; www.theralase.com/press/TLT_Operations_Manager-03-21-2011.pdf

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on TwitterFollow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

Flexible, Thixotropic, One Component Dual Cure Epoxy

Dec. 1, 2023
Master Bond UV23FLDC-80TK is a moderate viscosity, cationic type system that offers both UV light and heat curing mechanisms. It cures readily within 20-30 seconds when exposed...

MRF Polishing

Dec. 1, 2023
Welcome to Avantier, your esteemed partner in optical solutions for over five decades. With a legacy of expert knowledge, we invite you to delve into the realm of precision optics...

Fluorescence Microscopy Part 1: Illuminating Samples for High-Resolution Imaging

Dec. 1, 2023
Illuminating Samples Fluorescence microscopy is a powerful imaging technique widely used in various fields, especially in biomedical research, to visualize and study fluorescently...

Photonics Business Moves: December 1, 2023

Dec. 1, 2023
Here are the top four photonics business moves that made headlines during the week ending December 1, 2023.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!